Douglas E. Paull, MD, MS and Paul N. Uhlig, MD, MPA
Risk managers can help patient-subjects and clinician-researchers make informed novel device implantation decisions in the absence of preclinical trial data.
AMA J Ethics. 2020;22(11):E911-918. doi:
10.1001/amajethics.2020.911.
William F. Parker, MD, MS and Marshall H. Chin, MD, MPH
Given organ scarcity, transplantation programs state that patient promises of compliance cannot be taken at face value, excluding candidates who are deemed untrustworthy.
AMA J Ethics. 2020;22(5):E408-415. doi:
10.1001/amajethics.2020.408.
Drs Katrina Bramstedt and Ana Iltis discuss the development of QoL assessment tools to help patient-subjects considering reconstructive transplantation.
Feminism plays critical roles in innovating health care policies and practices. Feminist insights into clinicians as gatekeepers to gender-transition interventions can help resist tendencies to pathologize transgender.
AMA J Ethics. 2016;18(11):1132-1138. doi:
10.1001/journalofethics.2016.18.11.msoc1-1611.
One transgender patient draws upon his transition experiences to suggest strategies for health care professionals looking to be more responsive to transgender patients’ needs.
AMA J Ethics. 2016;18(11):1139-1146. doi:
10.1001/journalofethics.2016.18.11.mnar1-1611.